Skip to content
value.today

AnaBios Corp

BiotechnologyFounded 2009

Formerly AnaBioCardia Corporation

Total raised
$15 M
4 rounds on record
Latest round
$7 M
May 2022
First round on record
Mar 2011
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of AnaBios Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2022$7 MNo. 4$2 to $10 million

AnaBios Corp: Raise no. 4, May 2022

Investors in this round

1 investor had bought by the notice of Jun 9, 2022: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $7 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre Ghetti · Executive Officer
  • Jack E Reynolds · Executive Officer, Director
  • Paul E Miller · Executive Officer
  • David E Anderson · Director
  • Melanie E Fan · Director
  • Peter E Crowley · Director
  • Richard E Erdman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andre Ghetti, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 9, 2022. Read the notice at the SEC.

equitySEC
Dec 2019$1 MNo. 3Under $2 million

AnaBios Corp: Raise no. 3, Dec 2019

Investors in this round

16 investors had bought by the notice of Jun 5, 2020: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $7 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$490,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre Ghetti · Executive Officer
  • George E Goldsmith · Executive Officer
  • Jack E Reynolds · Executive Officer, Director
  • Martin E Waters · Executive Officer
  • Paul E Miller · Executive Officer
  • Peter E Crowley · Executive Officer, Director
  • Richard E Erdman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • ARCADIA SECURITIES, LLC (CRD 44656) · New York, New YorkSold in CA, CT, FL, HI, MA, MI, NJ, NY, WY

Remarks in the notice

  • On fees: “Number assumes a 7% commission on the maximum offering amount. The placement agent will also receive warrants up to 10% of the aggregate number of shares sold and will be entitled to receive $50,000 for reimbursement of expenses related to the offering.”

Signed by Andre Ghetti, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 5, 2020. Read the notice at the SEC.

equitySEC
May 2016$6 MNo. 2$2 to $10 million

AnaBios Corp: Raise no. 2, May 2016

Investors in this round

63 investors had bought by the notice of Jun 21, 2017: 63 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $8 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$254,100
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andre Ghetti · Executive Officer, Director
  • Jack J. Reynolds · Executive Officer, Director
  • Martin J. Waters · Executive Officer
  • Paul Miller · Executive Officer
  • George F. Goldsmith · Director
  • Peter F. Crowley · Director
  • Richard F. Erdman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • CIM Securities, LLC · broker-dealer CIM Securities, LLC (CRD 120852) · Centennial, ColoradoSold in CA, CO, CT, FL, HI, IL, MI, NJ, NY, SC, TX, WI, WY
  • Brookline Group, LLC · broker-dealer Brookline Group, LLC (CRD 153587) · Birmingham, AlabamaSold in AL

Remarks in the notice

  • On the amounts: “$613,251.37 in conversion of promissory notes to Series B Preferred Stock (principal & interest); $4,254,710.00 in new money; $885,556.71 in conversion of promissory notes to Series A Preferred Stock (principal & interest)”

Signed by Andre Ghetti, President & CEO. Source: SEC Form D and 2 amendments, newest notice filed Jun 21, 2017. Read the notice at the SEC.

equitySEC
Mar 2011$1 MNo. 1Under $2 million

AnaBios Corp: Raise no. 1, Mar 2011

Investors in this round

39 investors had bought by the notice of Sep 12, 2011: 39 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Andrea P. Ghetti · Executive Officer
  • Jack A. Reynolds · Executive Officer, Director
  • Martin J. Waters · Executive Officer
  • Paul E. Miller · Executive Officer
  • Stephen F. Flaim · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jack A. Reynolds, Ceo. Source: SEC Form D and 3 amendments, newest notice filed Sep 12, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • AnaBios Corp chose not to state its revenue in its newest notice of a funding round (Jun 2022).

    SEC Form D · Jun 2022

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2022

That is all the official record says: AnaBios Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of AnaBios Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 63 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by AnaBios Corp
NameRoleNamed in
Andre GhettiExecutive officerJun 2022
Jack E ReynoldsExecutive officerJun 2022
Paul E MillerExecutive officerJun 2022
George E GoldsmithExecutive officerJun 2020
Martin E WatersExecutive officerJun 2020
Peter E CrowleyExecutive officerJun 2020
Jack J. ReynoldsExecutive officerJun 2017
Martin J. WatersExecutive officerJun 2017
Paul MillerExecutive officerJun 2017
Andrea P. GhettiExecutive officerSep 2011
Jack A. ReynoldsExecutive officerSep 2011
Paul E. MillerExecutive officerSep 2011
Ian WisenbergExecutive officerJun 2011
David E AndersonDirectorJun 2022
Jack E ReynoldsDirectorJun 2022
Melanie E FanDirectorJun 2022
Peter E CrowleyDirectorJun 2022
Richard E ErdmanDirectorJun 2022
Andre GhettiDirectorJun 2017
George F. GoldsmithDirectorJun 2017
Jack J. ReynoldsDirectorJun 2017
Peter F. CrowleyDirectorJun 2017
Richard F. ErdmanDirectorJun 2017
Jack A. ReynoldsDirectorSep 2011
Stephen F. FlaimDirectorSep 2011